Texas A&M Center Adds Mobile Cleanrooms - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Texas A&M Center Adds Mobile Cleanrooms



Walker Barrier Systems, a producer of isolation and containment equipment, has built and delivered the first of eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing (CIADM).

The Texas A&M Center for Innovation is home to the National Center for Therapeutics Manufacturing (NCTM), which provides a facility for the development and production of vaccines and therapeutics for use in clinical trials. The addition of eight new mobile clean rooms to theNCTM will increase the development and manufacturing capacity of the CIADM.

The Walker Barrier Systems mobile clean room design will allow the NCTM to manufacture clinical grade materials at increased levels of compliance. Walker Barrier Systems units are built to support a wide range of processes and platforms that will be required by CIADM to manufacture biosecurity medical countermeasures.

Construction of the mobile clean rooms began in May 2013, and all eight are expected to be in operation at the NCTM by early 2014. The first unit was delivered in January 2014.

Source: Walker Barrier Systems

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here